Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

452 public trials 124 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Completed

Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)

NCT01933334

Conditions
Connective Tissue Diseases, Lung Diseases, Lung Diseases, Interstitial, +6 more
Locations
  • Mayo Clinic, Scottsdale Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford University School of Medicine Redwood City, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 22 locations
View Trial Details
Completed

Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease

NCT01309997

Conditions
Connective Tissue Diseases, Graft Versus Host Disease, Graft vs Host Disease, +5 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients

NCT00377949

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Hypertension, +12 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

NCT01651143

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • Investigational Site Number 840006 Scottsdale, Arizona, United States
  • Investigational Site Number 840003 Washington D.C., District of Columbia, United States
  • Investigational Site Number 840004 Baltimore, Maryland, United States
  • Investigational Site Number 840001 Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions